GeneDx Holdings (WGS) Short term Debt (2020 - 2023)

GeneDx Holdings has disclosed Short term Debt across 4 years of filings, most recently posting $4.3 million for Q1 2023.

• In Q1 2023, Short term Debt rose 33.3% year-over-year to $4.3 million; the TTM figure through Mar 2023 stood at $4.3 million (up 33.3% YoY), while the FY2022 annual figure was $3.6 million, up 36.98% from the prior year.
• Short term Debt rose to $4.3 million in Q1 2023, from $3.6 million in the prior quarter.
• Over the last five years, Short term Debt for WGS reached as high as $4.3 million in Q1 2023 and fell as low as $797000.0 in Q1 2021.
• The 4-year median for Short term Debt is $2.1 million (2022), against an average of $2.3 million.
• The widest YoY moves for Short term Debt: up 306.15% in 2022, down 28.28% in 2022.
• A 4-year view of Short term Debt shows it stood at $1.4 million in 2020, then surged by 84.07% to $2.6 million in 2021, then surged by 36.98% to $3.6 million in 2022, then advanced by 20.09% to $4.3 million in 2023.
• According to Business Quant data, Short term Debt over the past three periods registered $4.3 million, $3.6 million, and $1.8 million for Q1 2023, Q4 2022, and Q3 2022 respectively.